1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Focal Segmental Glomerulosclerosis: new trials by email Literature Review of Focal Segmental Glomerulosclerosis trials Research Report on Focal Segmental Glomerulosclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects Dapagliflozin - Focal Segmental Glomerulosclerosis | Phase 4 | Completed | University Health Network, Toronto | 10 | 2015-09-01 | 2018-01-16 |
Glomerulosclerosis, Focal Segmental (1) · Proteinuria (1) · Renal Insufficiency, Chronic (1)
Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glomerulonephritis (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nephritis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Signs and Symptoms (1) · Urination Disorders (1) · Urogenital Diseases (1) · Urologic Diseases (1)
dapagliflozin (1)
University Health Network, Toronto (1)
Canada (1)